Plague vaccines: Current developments and future perspectives

Valentina A. Feodorova, Vladimir L. Motin

Research output: Contribution to journalReview article

31 Scopus citations

Abstract

Despite many decades of intensive studies of Yersinia pestis, the causative agent of plague, there is no safe and efficient vaccine against this devastating disease. A recently developed F1/V subunit vaccine candidate, which relies mainly on humoral immunity, showed promising results in animal studies; however, its efficacy in humans still has to be carefully evaluated. In addition, those developing next-generation plague vaccines need to pay particular attention to the importance of eliciting cell-mediated immunity. In this review, we analyzed the current progress in developing subunit, DNA and live carrier platforms of delivery by bacterial and viral vectors, as well as approaches for controlled attenuation of virulent strains of Y. pestis.

Original languageEnglish (US)
Article numbere36
JournalEmerging Microbes and Infections
Volume1
DOIs
StatePublished - Dec 1 2012

Keywords

  • Plague
  • Protective antigens
  • Vaccine
  • Yersinia pestis

ASJC Scopus subject areas

  • Virology
  • Parasitology
  • Microbiology
  • Immunology
  • Drug Discovery
  • Epidemiology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Plague vaccines: Current developments and future perspectives'. Together they form a unique fingerprint.

  • Cite this